Tsuyoshi Kihara M. D.

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Strictly speaking, therefore, all cases have to be subjected to biopsy or all seemingly benign lesions have to be periodically followed lest cancer be overlooked. If those suspected for cancer be the only target for biopsy, 5% of all the cases will be biopsied with the 0.3% risk of overlooking cancer. Then, how about the accuracy of biopsy ? In early(More)
  • 1